arrow
J

Jolien Schaeverbeke

KU Leuven
H指数:23
被引数:1,543

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multimodal Retinal Imaging for the Detection of Early Alzheimer’s Disease: Combining Biochemical, Structural, and Vascular Biomarkers

多模态视网膜成像用于早期阿尔茨海默病的检测:结合生化、结构和血管生物标志物

2026-09-080
OA
Volumetric postmortem MRI of the medial temporal lobe in Alzheimer’s disease and related disorders: methodological advances and implications for in vivo biomarker development

阿尔茨海默病及相关疾病的内侧颞叶容积尸检MRI:方法学进展及其对活体生物标志物开发的启示

2026-07-020
OAAI
A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions

GOLGA8A的重复扩增是泛素阳性内含物的非典型额颞叶变性的主要危险因素

2026-03-120
OAAI
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease

APOE基因型与脑脊液蛋白质组的关联揭示了阿尔茨海默病中不同的保护机制和风险机制

2025-10-140
OAAI
Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus

阿尔茨海默病研究中分享个体研究结果的推荐方法:一项多学科专家德尔菲共识

2025-09-250
PRE
Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiology

认知功能正常个体中疑似非阿尔茨海默病病理生理机制的脑脊液蛋白质组学分析

2025-06-200
OAAI
Blood-based multivariate methylation risk score for cognitive impairment and dementia

认知障碍和痴呆的基于血液的多变量甲基化风险评分

2024-08-281
OAAI
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study

Emif-ad研究中与阿尔茨海默病CSF生物标志物相关的血液DNA甲基组学特征

2024-08-280
OAAI
Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studies
2024-07-183
OAAI
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
2024-07-061
OA
Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET

血浆pTau181和pTau217与淀粉样蛋白PET同样预测无症状淀粉样蛋白的积累

2024-05-232
OAAI